Company Cancer Research 2016 Srl with Fiscal Code 36070953
recorded a turnover of 2024 of
47.337,
with a net profit of
27.196
and having an average number of employees of
- .
The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Cancer Research 2016 Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
14.827
18.947
21.988
25.895
17.960
32.090
38.174
48.182
47.337
Total Income - EUR
-
14.827
18.947
21.988
25.895
17.977
32.506
38.392
48.182
47.686
Total Expenses - EUR
-
503
9.619
10.404
18.605
18.841
18.171
17.113
18.706
15.267
Gross Profit/Loss - EUR
-
14.324
9.328
11.584
7.290
-865
14.335
21.279
29.476
32.420
Net Profit/Loss - EUR
-
13.879
8.761
10.924
6.505
-1.384
13.360
20.127
24.760
27.196
Employees
-
0
0
0
0
0
0
0
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -1.2%, from 48.182 euro in the year 2023, to 47.337 euro in 2024.
The Net Profit increased by 2.575 euro, from 24.760 euro in 2023, to 27.196 in the last year.
Check the financial reports for the company - Cancer Research 2016 Srl
Financial Rating - CANCER RESEARCH 2016 SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Cancer Research 2016 Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Cancer Research 2016 Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Cancer Research 2016 Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Cancer Research 2016 Srl - CUI 36070953
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
21.751
15.066
8.223
61.479
48.103
33.889
21.040
10.615
2.508
Current Assets
-
2.573
7.618
6.191
11.866
13.934
18.218
8.804
24.309
9.320
Inventories
-
0
0
0
0
0
0
0
0
0
Receivables
-
1.834
1.156
1.560
5.421
1.463
2.796
4.895
5.665
1.578
Cash
-
739
6.462
4.630
6.445
12.471
15.422
3.909
18.643
7.742
Shareholders Funds
-
13.923
22.449
14.299
20.528
18.754
31.699
15.371
23.603
7.682
Social Capital
-
45
44
43
42
41
40
41
40
40
Debts
-
10.401
235
114
52.817
43.283
20.408
14.473
11.320
4.147
Income in Advance
-
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7219 - 7219"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
9.320 euro in 2024 which includes Inventories of
0 euro, Receivables of
1.578 euro and cash availability of
7.742 euro.
The company's Equity was valued at
7.682 euro, while total Liabilities amounted to
4.147 euro.
Equity decreased by -15.790 euro, from 23.603 euro in 2023, to 7.682 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Cancer Research 2016 Srl